Society for Immunotherapy of Cancer (SITC) Annual Meeting
November 08 - November 12, 2022
Details are as follows:
Title: Interim Clinical Update of the Phase 1b Trial of ATRC-101 as Monotherapy or in Combination with Pembrolizumab for Select Advanced Solid Tumors
Poster / Abstract Number: 717
Date / Time: November 10 - November 11, 9:00 a.m. - 9:00 p.m. ET
Title: Discovery and Pre-Clinical Development of a Novel and Differentiated EphA2-Targeted Antibody in Multiple Bispecific Formats
Poster / Abstract Number: 1194
Date / Time: November 10 - November 11, 9:00 a.m. - 9:00 p.m. ET
Supporting Materials
SITC 2022 – ATRC-101 Poster 5.9 MB
SITC 2022 – EphA2 Poster 3.7 MB